COMPANY

Prime Vitality, Inc. dba Prime Peptides

Name: Prime Vitality, Inc. dba Prime Peptides peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

Prime Vitality, Inc. dba Prime Peptides: warning letter recipient for Retatrutide, Semaglutide, Tirzepatide, as stated by public registers.

WARNING LETTER RECIPIENT

Received an FDA warning letter naming the peptide.

Retatrutide	Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters
Semaglutide	Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters
Tirzepatide	Unapproved New Drugs/Misbranded, 2024-12-10 Regulator FDA warning letters

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.